Document is current

Article History

Accepted: 14 November 2024

First Online: 25 February 2025

Declarations

:

: No animal or human subjects were used in this study.

: JES recently received a Brain Travel Grant related to this work. LA receives payment from Elsevier for editorial work. KI is clinical lead for the Southern Gambling Service and receives a stipend from Elsevier for journal editorial work. NAF has recently held research or networking grants from the NIHR, COST Action, Orchard, Horizon Europe, UKRI; participated as investigator in a study where the experimental drug was donated by Compass Pathways; accepted travel and/or hospitality expenses from the BAP, ECNP, RCPsych, CINP, World Psychiatric Association; received payment from Elsevier for editorial duties and the Mental Health Academy and Children and Screens for lecturing. She leads an NHS treatment service for OCD. She holds Board membership for various registered charities linked to OCD. She gives expert advice on psychopharmacology to the UK MHRA. JEG has received research grants from Janssen and Biohaven Pharmaceuticals. He receives yearly compensation from Springer Publishing for acting as Editor-in-Chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Inc., Norton Press, and McGraw Hill. SRC and JEG co-developed the CHI-T. SRC receives honoraria from Elsevier for journal editor work.